Sign inJoin waitlistJoin the waitlist

Anna Narezkina

Director, Cardio-Oncology Program · University of California (San Diego) Medical Center

Credentials: · · · · ·

History

University of California (San Diego) Medical Center
Present

Cardiovascular Disease
University of California-San Diego
2008–2011
Internal Medicine
University of California (San Diego) Medical Center
2006–2008
Doctor of Medicine
2002–2006

Research

Genome-wide analyses of avian sarcoma virus integration sites
Journal of Virology · 2004 · First of 8 authors · 136 citations
Molecular mechanisms of anthracycline cardiovascular toxicity
Review · Clinical Science · 2021 · First of 3 authors · 64 citations
Immune checkpoint inhibitor-associated myocarditis: a novel risk score
European Heart Journal · 2026 · 57 citations

Nausheen Akhter
4 papers
Aarti Asnani
3 papers
Danette Flint
3 papers
Douglas Johnson
3 papers
Elizabeth Gaughan
3 papers
Han Zhu
3 papers
IT
Isik Turker
3 papers
Javid Moslehi
3 papers
JP
John Power
3 papers · 2 as a fellow
Joshua Levenson
3 papers
Lauren Baldassarre
3 papers
Nicolas Palaskas
3 papers

Clinical trials

Low-dose CT-based Method for Detection of Subclinical Anthracycline-induced Cardiotoxicity
Principal investigator · Completed
University of California, San Diego
2018–2021
A Multicenter Trial Assessing the Impact of Lipoprotein(a) Lowering With Pelacarsen (TQJ230) on the Progression of Calcific Aortic Valve Stenosis
Site PI · Recruiting · Phase 2
Novartis Pharmaceuticals
2024–2030
Atrial Fibrillation Among Patients With Hematologic Malignancies on Tyrosine Kinase Inhibitor Therapy
Sub-investigator · Not yet recruiting
Tina Baykaner
2026–2031